Wordt geladen...
Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1
Gemcitabine is a deoxycytidine analog used in the treatment of various solid tumors. However, tumors often develop resistances over time, which becomes a major issue for most gemcitabine-related chemotherapies. In the present study, a previously reported stearoyl gemcitabine nanoparticle formulation...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3236813/ https://ncbi.nlm.nih.gov/pubmed/21851843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2011.08.004 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|